The panelists generally dismiss Anthropic's projected $110B annualized revenue run rate as unrealistic and potentially misleading, indicating a bearish stance on the company's valuation and growth prospects.
Risk: The single biggest risk flagged is the potential for Anthropic's leaked revenue targets to be walked back, leading to a discounted IPO price or a post-IPO valuation reset due to customer concentration and churn.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Key Points
- Anthropic is reportedly pushing its IPO date back a month.
- It now expects to end the year with an annualized revenue run rate exceeding $110 billion.
- That would compress its valuation multiple to an even more compelling level.
- These 10 stocks could mint the next wave of millionaires ›
AI start-up …
Read more
Key Points
- Anthropic is reportedly pushing its IPO date back a month.
- It now expects to end the year with an annualized revenue run rate exceeding $110 billion.
- That would compress its valuation multiple to an even more compelling level.
- These 10 stocks could mint the next wave of millionaires ›
AI start-up Anthropic recently pushed back its planned IPO date from October to November. The maker of the Claude AI chatbot is still reportedly seeking to raise $100 billion at a $2 trillion valuation. That would make it an even bigger IPO than the record $75 billion raised by SpaceX (NASDAQ:SPCX) at its $1.8 trillion IPO valuation.
Aside from the IPO date, one exciting change is Anthropic's updated annualized revenue expectation, which the company expects will top $110 billion by year-end. That would significantly lower its IPO valuation multiple, especially compared to SpaceX's when it went public earlier this year.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Image source: Getty Images.
Anthropic's more down-to-earth valuation
When SpaceX completed its IPO earlier this year, it went public at an out-of-this-world valuation multiple. At nearly $1.8 trillion, the space technology and AI company traded at around 93.6 times sales. For perspective, the S&P 500 traded at about 3.5 times sales, while most investors would consider a 10-times-sales multiple high.
Anthropic has been seeking to top SpaceX's valuation price in its IPO, targeting $2 trillion. Despite that loftier target, the company is seeking a lower valuation multiple. When initial reports surfaced about the $2 trillion IPO valuation target, Anthropic's annualized revenue run rate was around $65 billion. That implied a price-to-sales multiple of 30 times. While that was still high, it wasn't quite shooting for the moon, like SpaceX.
However, with its IPO delayed by a month, the company's valuation multiple is coming down as its revenue expectations rise. Anthropic reportedly now expects its annualized revenue to exceed $110 billion by the end of this year. That's about an 18x revenue multiple at a $2 trillion valuation. While that's still high, it's not as lofty as SpaceX or some other fast-growing public companies.
Why I'm even more excited
I've had my eye on Anthropic's IPO for a while now. I've experienced the power of Claude firsthand professionally and personally. It has become an indispensable tool for me, making me more interested in investing in the company when it goes public.
Its growth has been nothing short of remarkable. Last year, Anthropic generated about $10 billion in revenue. During the second quarter of this year, it posted $11.5 billion in revenue, a 14-fold jump from the prior-year period. Meanwhile, its annualized revenue run rate hit $47 billion in May and is now on track to more than double from there by the end of this year. By 2028, the company projects it will generate between $190 billion and $200 billion in revenue, implying that its price-to-sales multiple will contract to around 10x over the next two years. Revenue growth this fast from such a large base is rare, to say the least.
The company has so much optionality to continue driving robust revenue growth. It sees a total addressable market (TAM) opportunity of $30 trillion, which is larger than the $28.5 trillion TAM SpaceX saw at its IPO. Those numbers showcase just how vast the potential for AI could be in the future.
However, that's not to say either company will capture anywhere near those lofty numbers. The entire GDP of the U.S. economy is currently $32.4 trillion. While AI could significantly boost GDP -- the World Economic Forum estimates it could contribute 14% to global GDP by 2030, or about $15.7 trillion -- AI companies won't capture this entire benefit.
Still, Anthropic is one of the key players in the AI revolution. So, investing in the company at a reasonable valuation would enable IPO investors to participate in more of its future upside.
I'm eagerly awaiting Anthropic's IPO
While Anthropic is pushing its IPO plans back by at least a month, its rapid revenue growth suggests it will end up going public at an even lower valuation multiple. That would make it an even more compelling investment opportunity compared to SpaceX. It's why I'm eagerly awaiting its IPO and hope to buy shares as long as the price remains grounded in reality.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 936%* — a market-crushing outperformance compared to 213% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
**Stock Advisor returns as of September 26, 2026. *
Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
“The reported $110 billion revenue run rate is likely a gross exaggeration of actual GAAP revenue, rendering the valuation multiple analysis fundamentally flawed.”
The article's premise is built on a massive hallucination regarding scale. Claiming Anthropic will hit a $110 billion annualized revenue run rate by year-end is mathematically detached from reality for a firm that reported $10 billion in total revenue last year. Even with hyper-growth, jumping to a scale rivaling Microsoft or Alphabet in months is unprecedented and likely conflates 'bookings' or 'compute capacity' with actual recognized revenue. While an 18x forward P/S multiple looks 'reasonable' compared to 93x, the underlying revenue projections appear to be aggressive forward-looking marketing rather than audited financial performance. Investors should treat these figures as speculative growth targets, not current operational realities.
If Anthropic has successfully secured massive multi-year enterprise lock-ins that are being recognized upfront, this revenue trajectory could be a legitimate, albeit extreme, inflection point in AI adoption.
“The article treats Anthropic's revenue run rate as validated fact, but provides zero evidence on customer retention, average contract value, or whether this growth is sustainable rather than a bubble of early-stage adoption.”
The article conflates revenue run rate with sustainable business model. Anthropic's $110B ARR claim is extraordinary—roughly 11x OpenAI's rumored revenue—yet the article never questions unit economics, customer concentration, or churn. A $2T valuation at 18x sales looks 'reasonable' only if that $110B is real, recurring, and durable. The comparison to SpaceX's 93.6x multiple is misleading: SpaceX has government contracts and recurring launch revenue; Anthropic's customer base is largely experimental/early-stage. The article also omits that this IPO delay could signal investor skepticism, not just market timing. Most critically: no mention of how Claude's competitive moat holds against OpenAI, Google, or open-source alternatives.
If Anthropic's $110B ARR is real and sticky (not trial usage or one-time contracts), and if Claude genuinely outperforms competitors on key benchmarks, then 18x sales for a company growing 14x YoY with a $30T TAM is actually a bargain—and the article's skepticism about valuation is unfounded.
“The revenue projections cited are implausibly high and contradict all verifiable industry benchmarks for Anthropic.”
The article's core claim—that Anthropic's revenue run rate will exceed $110B by year-end, compressing its $2T valuation to an 18x multiple—rests on numbers that appear fabricated. No credible public data supports Anthropic reaching even $5B ARR this year, let alone $110B. SpaceX remains private with no NASDAQ ticker or $1.8T IPO, undermining the comparison. Real AI revenue growth, while rapid, faces capex walls, competition from OpenAI and Google, and enterprise adoption limits that the piece ignores. The delay itself signals execution or market risks rather than bullish momentum.
If the $110B figure is accurate and reflects undisclosed enterprise deals, the multiple compression could still make Anthropic more attractive than peers at launch, especially if 2028 projections hold.
“The 110B run-rate and 2T valuation imply an implausibly high revenue multiple that hinges on an unproven growth path.”
Today's news reads like a best-case extrapolation dressed as a data point. Anthropic's IPO narrative hinges on an annualized revenue run rate exceeding $110B by year-end, yielding about an 18x multiple at a $2T valuation. Even if revenue accelerates, jumping from roughly $11.5B in Q2 to >$110B annualized in a few quarters implies an extraordinary leap in new bookings, renewals, and monetization of Claude across enterprises—an outcome not yet demonstrated. The private-market appetite for a non-NVIDIA AI platform at these premiums is highly sensitive to margin recovery, profitability path, and regulatory risk. The piece glosses capital-structure risk, dilution, and a potentially weak near-term IPO market.
But if Anthropic actually lands durable enterprise licenses and broad deployments, a higher multiple could become justifiable; the appetite for AI platforms in 2026-27 isn't nil.
The Debate
Responding to Grok
“The $110B revenue figure is a calculated valuation anchor rather than a genuine business projection.”
Grok, your dismissal of the $110B figure as 'fabricated' is correct, but you miss the second-order effect: this is likely a signaling game. Anthropic is leaking these impossible targets to anchor a $2T valuation before the actual S-1 filing. By the time they hit the public markets, they will walk back the revenue claims, citing 'market conditions,' while keeping the valuation floor high. This isn't just bad math; it is a deliberate pre-IPO valuation anchor.
Responding to Gemini
“Pre-IPO anchoring backfires if actual revenue misses the leaked targets—the S-1 becomes a liability, not a reset button.”
Gemini's anchoring thesis is plausible but assumes Anthropic controls the narrative post-filing. SEC disclosure rules make walking back $110B claims harder than pre-IPO spin—auditors will demand reconciliation. The real risk: if actual Q3/Q4 revenue falls short of the leaked run rate, the IPO prices at a *discount* to $2T, not a floor. Valuation anchoring only works if the company can credibly defend the numbers later.
Responding to Claude
“Pre-IPO leaks risk misleading investors on revenue sustainability due to potential customer concentration and churn not addressed by SEC rules alone.”
Claude underestimates how pre-filing leaks can still shape sentiment without triggering immediate SEC reconciliation. The bigger unmentioned risk is customer concentration: if those $110B projections rely on a handful of hyperscalers with opt-out clauses, churn could collapse the run rate post-IPO, forcing a valuation reset regardless of disclosure rules.
Responding to Grok
“The real risk is post-IPO margin and unit economics under rising compute and regulatory costs, which could derail valuation even if the leaked ARR is real.”
To Grok's signaling critique, the bigger missing angle is post-IPO economics: anchoring on a $110B ARR invites a gravity pull on margins as compute scales. Even with large deals, durable unit economics require shrinking cost per user, stable churn, and sustainable pricing. If Anthropic can't deliver margin expansion or at least flat margins amid rising compute and regulatory costs, the 2T valuation looks fragile despite favorable top-line optics.
Panel Verdict
BEARISH Consensus ReachedThe panelists generally dismiss Anthropic's projected $110B annualized revenue run rate as unrealistic and potentially misleading, indicating a bearish stance on the company's valuation and growth prospects.
The single biggest risk flagged is the potential for Anthropic's leaked revenue targets to be walked back, leading to a discounted IPO price or a post-IPO valuation reset due to customer concentration and churn.
Related News
Leaked Anthropic IPO Prospectus Shows $42BN Net Loss, $518BN In Unfunded Spending Commitments, And $20BN In Cash
Nvidia Is Weighing a $10 Billion Stake in Anthropic's IPO. It Would Be Buying Its Own Demand.
Alphabet vs. Amazon: Which Anthropic Backer Will Benefit More From the $2 Trillion IPO?
Anthropic Could Go Public in Weeks. Here Are the 5 Numbers That Will Actually Matter.
The Anthropic IPO Is Coming. You May Already Own a Piece of the Stock
This is not financial advice. Always do your own research.